Form 4 for REGN Regeneron Pharmaceuticals
Accepted 2023-03-27 00:00:00 ET · period of report 2023-03-23 · accession 0001883850-23-000060 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-03-27 | 2023-03-23 | REGN | Fenimore Christopher R. | SVP Ctrl | S - Sale | $806.47 | -2,192 | 18.4K | -11% | -$1.77M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-03-23 | S | D | 2,192 | $806.47 | 18,409 | D | — | — |